Open AccessThe Off-Label Use of Hydroxychloroquine in Prophylaxis and Treatment of COVID-19
Author(s) -
Ashish Paul
Publication year - 2020
Publication title -
international healthcare research journal
Language(s) - English
Resource type - Journals
ISSN - 2456-8090
DOI - 10.26440/ihrj/0401.04339
Subject(s) - hydroxychloroquine , medicine , pandemic , covid-19 , intensive care medicine , social distance , public health , disease , population , drug , virology , environmental health , infectious disease (medical specialty) , pharmacology , nursing , outbreak
Coronavirus pandemic has covered the entire globe only in a few months and has been declared as a public health emergency due to a very high morbidity as well as mortality rate. Till date no curative measure is available for this fatal disease and only social distancing has been of some help in prevention. However, anti-malarial drug hydroxychloroquine is being tried for prophylaxis and treatment at early stages of the disease although it is not an approved indication for this drug which has given some hope to health care professionals and the affected population.